Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection

MeSH terms

• Acquired Immunodeficiency Syndrome / transmission*
• Antibodies, Viral / analysis
• Chemical Fractionation / methods
• Deltaretrovirus / immunology
• Drug Contamination
• Humans
• Immunoglobulins / administration & dosage
• Immunoglobulins / adverse effects*
• Injections, Intravenous